Search

everythinglearnresearchcommunity

for

Search:↓

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

WYE-130600 may cause skin thickening and irritation.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

ITK inhibitors may effectively treat alopecia areata.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

EGFR inhibitors for lung cancer can cause severe skin issues.

Cancer treatments often cause skin, nail, and hair problems.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Nilotinib can cause generalized keratosis pilaris.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Skin reactions from cancer treatments might predict how well the treatments work.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.